Predictive value of ACEF Ⅱ score and serum RBP4 and NT-proBNP levels for prognosis of elderly T2DM patients with acute coronary syndrome after PCI
CSTR:
Author:
Affiliation:

(1. Department of Cardiology,Xingtai 054000, Hebei Province, China ;2. Department of Endocrinology, Xingtai 054000, Hebei Province, China;3. Clinical Laboratory, Xingtai Central Hospital, Xingtai 054000, Hebei Province, China)

Clc Number:

Fund Project:

This work was supported by the Self-Funded Project of Key Research and Development Plan of Xingtai(2024ZC195).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To explore the predictive value of age, creatinine and ejection fraction (ACEF) Ⅱ score, and serum retinol binding protein 4 (RBP4) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels for the prognosis in elderly patients with type 2 diabetes mellitus (T2DM) complicated with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). Methods Clinical data of 128 elderly T2DM patients with ACS undergoing PCI in our hospital from January 2022 to September 2023 were collected. According to whether major adverse cardiovascular and cerebrovascular events occurred, they were divided into good prognosis group (99 cases) and poor prognosis group (29 cases). SPSS statistics 24.0 was used for data analysis. Depending on data type, t test, Mann-Whitney U test,χ2 test or Fisher′s exact probability test was applied for comparison between groups. Receiver operating characteristic (ROC) curve was plotted to evaluate the predictive value of ACEFⅡ score and serum RBP4 and NT-proBNP levels for poor prognosis, and binary logistic regression analysis was used to determine the influencing factors of prognosis in these patients after PCI. Results Among the 128 elderly T2DM patients with ACS, 29 (22.66%) had major adverse cardiovascular and cerebrovascular events at 6 months after PCI, including 7 cases of heart failure, 5 cases of stroke, 7 cases of myocardial infarction, 9 cases of secondary revascularization, and 1 case of cardiac death. The poor prognosis group demonstrated significantly lower postoperative administration rate of dapagliflozin, but higher ACEFⅡ score and serum levels RBP4 and NT-proBNP than the good prognosis group (all P<0.05). ROC curve analysis showed that the areas under the curve (AUC) of ACEFⅡ score and serum RBP4 and NT-proBNP levels in predicting poor prognosis after PCI in elderly T2DM patients with ACS was 0.745 (95%CI 0.640-0.850, P<0.05), 0.871 (95%CI 0.803-0.939, P<0.05) and 0.796 (95%CI 0.697-0.902, P<0.05), respectively. Binary logistic regression analysis suggested that ACEFⅡ score ≥1.59 (OR=3.357,95%CI 1.688-6.676, P<0.05), RBP4 ≥42.71 mg/L (OR=3.873,95%CI 2.206-6.800, P<0.05), and NT-proBNP ≥603.58 ng/L (OR=3.725,95%CI 2.114-6.562, P<0.05) were all independent risk factors for poor prognosis in elderly T2DM patients with ACS after PCI, and postoperative use of dapagliflozin (OR=0.380,95%CI 0.011-0.782, P<0.05) was an independent protective factor. Conclusion ACEFⅡ score, serum RBP4 and NT-proBNP levels can play a certain role in predicting the prognosis of elderly T2DM patients with ACS after PCI, and the postoperative use of dapagliflozin may be beneficial to improving the prognosis of the patients.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:August 21,2024
  • Revised:
  • Adopted:
  • Online: August 25,2025
  • Published:
Article QR Code